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ABSTRACT The effects of pharmacological interventions that modulate Ca21 homeodynamics and membrane potential in rat
isolated cerebral vessels during vasomotion (i.e., rhythmic ﬂuctuations in arterial diameter) were simulated by a third-order system
of nonlinear differential equations. Independent control variables employed in the model were [Ca21] in the cytosol, [Ca21] in
intracellular stores, and smooth muscle membrane potential. Interactions between ryanodine- and inositol 1,4,5-trisphosphate-
sensitive intracellular Ca21 stores and transmembrane ion ﬂuxes via K1 channels, Cl channels, and voltage-operated Ca21
channels were studied by comparing simulations of oscillatory behavior with experimental measurements of membrane potential,
intracellular free [Ca21] and vessel diameter during a range of pharmacological interventions. The main conclusion of the study is
that a general model of vasomotion that predicts experimental data can be constructed by a low-order system that incorporates
nonlinear interactions between dynamical control variables.
INTRODUCTION
Blood ﬂow and tissue perfusion normally exhibit a high
degree of temporal variability that is not simply attributable
to ﬂuctuations in heart rate and blood pressure. An important
contributory mechanism is the rhythmic vascular contractile
activity that is ubiquitous in arterioles, resistance arteries,
and conduit arteries—a phenomenon known as vasomotion.
Although the physiological beneﬁts of vasomotion remain
controversial, time-dependent regional redistributions in mi-
crovascular ﬂow ensure that all tissue elements ultimately
receive perfusion, and it has also been suggested that the
phenomenon represents an adaptive response because it is
enhanced in hemorrhagic shock and may then serve to pre-
serve tissue viability (reviewed in 1–3). Rhythmic activity
may also be observed in isolated arteries, both spontaneously
and after stimulation with constrictor agonists in otherwise
quiescent vessels (4–8). At the cellular level, vasomotion is
associated with oscillations in [Ca21]i and membrane poten-
tial, with uncoordinated ﬂuctuations in [Ca21]i in individual
smooth muscle cells becoming almost synchronous at the
onset of large-scale oscillatory activity (7–13). The mech-
anisms that underpin such entrainment involve electrical
and/or chemical coupling via gap junctions, since pharma-
cological interruption of direct cell-cell communication
suppresses rhythmic contractile activity in isolated arterial
segments (6,13,14).
In isolated rabbit and rat arteries, vasomotion often
exhibits patterns of behavior that are generic in nonlinear
systems, including period-doubling, quasiperiodic, and inter-
mittent routes for the transition from regular to chaotic be-
havior (5,15–19). Nonlinear statistical techniques have
provided estimates of the minimum number of underlying
dynamic control variables that contribute to vasomotion, and
in rabbit and rat arteries these generally give a value between
2 and 3, both in vitro and in vivo, with a value between 3 and
4 sometimes being obtained (1,5,16,20). Although we have
previously shown that a four-variable mathematical model
incorporating nonlinear interactions between the ion trans-
port systems that regulate arterial tone can successfully
simulate complex chaotic patterns of response in isolated
rabbit arteries (17), the predominance of low dimensional
behavior suggests that in many situations a three-variable
model could sufﬁce to reproduce the general patterns of
vasomotion observed experimentally. In this study, we there-
fore investigated the behavior of a model that employs [Ca21]
in the cytosol, [Ca21] in intracellular stores, and membrane
potential as the dominant control variables to deﬁne the
minimal components that can be used to model vasomotion.
In our previous model, regenerative intracellular Ca21-
induced Ca21 release was assumed to be mediated exclu-
sively via the ryanodine receptor (RyR), and a coexisting
inositol 1,4,5-trisphosphate (InsP3)-sensitive store was as-
sumed to provide a steady ﬂux of Ca21 into the cytosol. In this
model, we now incorporate a second Ca21-induced Ca21
release mechanism via the inositol 1,4,5-trisphosphate recep-
tor (InsP3R). This approach allows evaluation of the dynam-
ical consequences of differences in the kinetics of theRyR and
InsP3R and interactions between the two channels can be
studied by varying their relative contributions to intracellular
Ca21 movements.
The results of simulations were compared with the effects
of pharmacological interventions in the rat basilar artery and its
branches, inwhich rhythmic activity is observed spontaneously
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and does not require the application of an exogenous
constrictor agonist. Experimental data consisted of electro-
physiological measurements of membrane potential and
ratiometric imaging of smooth-muscle [Ca21]i, with changes
in vessel diameter continuously monitored by videomicro-
scopy. Two of the key control variables of the system were
therefore directly observable, thus allowing detailed valida-
tion of the dynamical contributions of the individual model
components. The model successfully reproduced the effects
of a broad range of pharmacological interventions and
allowed clariﬁcation of the different routes through which
agents that affect [Ca21]i and membrane potential modulate
vasomotion.
METHODS
Experimental methods
All experiments were performed in accordance with institutional guidelines
using male Wistar rats (14–17 days postnatal) that were anaesthetized with
ether and decapitated. After removal of the brain into cold (5–7C)
dissection buffer containing (mM) 3 3-(N-morpholino)propanesulphonic
acid (Mops), 1.2 NaH2PO4, 4.6 glucose, 2 pyruvate, 0.02 EDTA(Na), 0.15
albumin, 145 NaCl, 4.7 KCl, 2 CaCl2, and 1.2 MgSO4, a rectangular section
of the meninges containing the basilar artery and its primary and secondary
branches was isolated. The preparation was pinned to the bottom of a 1-ml
recording chamber which was perfused at a constant ﬂow rate (3 ml min1)
with Krebs solution containing (mM) 120 NaCl, 5 KCl, 25 NaHCO3,
1 NaH2PO4, 2.5 CaCl2, 2 MgCl2, and 11 glucose, gassed with 95% O2 and
5% CO2 and maintained at 33–34C.
Measurements of membrane voltage
and vasomotion
An individual primary or secondary branch of the basilar artery was
visualized by videomicroscopy and the diameter of the vessel continuously
monitored (Diamtrak (21)). After 20 min of superfusion with Krebs solution,
spontaneous contractions were routinely recorded in all arteries and
arterioles. Smooth muscle cells were impaled with sharp microelectrodes
ﬁlled with 0.5 MKCl (tip resistance 120–220MV), and membrane potential
records were ampliﬁed with an Axoclamp 2B (Axon Instruments, Foster
City, CA). Changes in membrane potential and changes in vessel diameter in
the same region were simultaneously recorded. After measurements in con-
trol Krebs solution, preparations were incubated in drugs up to a maximum
period of 30 min before being returned to control solution.
Measurements of intracellular calcium
In experiments in which changes in intracellular calcium concentration were
made, a small area of the meninges surrounding the primary and secondary
arteries was gently removed and the preparations incubated at room tem-
perature (22C) in modiﬁed Krebs solution containing reduced calcium (0.5
mM CaCl2), the detergent pluronic F-127 (0.01%), and the ratiometric
ﬂuorescent dye Fura-2 acetoxymethyl ester (5 mM) for 40 min. This was
followed by superfusion with warmed (34C) Krebs solution, containing 2.5
mM CaCl2 for 20 min. When viewed with 380 nm light at this time, only the
outer layer of smooth muscle cells could be visualized and no endothelial
cells were ever seen to be ﬂuorescent. No smooth muscle cells were loaded
if the meninges were left in place. Measurements of calcium were made in
individual smooth muscle cells or within an area of the vascular wall by
calculating the ratio of the ﬂuorescence emission recorded at 510 nm after
sequential excitation of the preparation with 340 and 380 nm light (F340/380;
Polychrome II illumination system; TILL Photonics, Gra¨felﬁng, Germany).
In the case of changes in calcium in the arterial wall, measurements were
made at 30 Hz with a photometry system (TILL Photonics) and recorded
with pCLAMP 8 (Axon Instruments). In the case of changes in [Ca21] in
individual smooth muscle cells, images were captured at 4 Hz using an
intensiﬁed cooled CCD camera (Princeton Instruments, Trenton, NJ) and
data processed using Axon Imaging Workbench (Axon Instruments). Simul-
taneous measurement of vessel diameter was made possible by continuous
image capture under infrared illumination (775 nm; Hamamatsu Performance
Vidicon camera, Hamamatsu City, Japan). To restrict exposure of the prep-
aration to ultraviolet light, measurements of calcium were made in control
Krebs solution, immediately after the equilibration period, and after drugs
had been present for 20 min.
Drugs and solutions
Drugs usedwere obtained from the following sources: 1-(6-((17b-3-methoxyestra-
1,3,5(10)-trien-17-yl) amino)-hexyl)-1H-pyrrole-2,5-dione (U73122), ni-
fedipine, 2-hydroxyethanesulfonic acid (sodium isethionate), niﬂumic acid,
charybdotoxin (Sigma Chemical, St. Louis, MO); Fura-2 acetoxymethyl
ester, pluronic acid (Molecular Probes, Eugene, OR); ryanodine (Biomol,
PlymouthMeeting, PA). U73122 and niﬂumic acid were dissolved in DMSO
as 104-fold stock solutions and diluted into Krebs solution. Nifedipine was
similarly dissolved in ethanol (104-fold stock) and charybdotoxin was dis-
solved in PBS containing 0.1%BSA as a 103-fold stock. All other drugs were
made up as 103-fold stock solutions in distilled water and diluted into Krebs
solution.
Formulation of the mathematical model
The model is based on an intracellular Ca21 oscillator that generates os-
cillatory activity via cyclical Ca21-induced Ca21 release (CICR) from in-
ternal stores located in the sarcoplasmic reticulum (SR). Since Ca21 released
into the cytosol is pumped out of the cell as well as being resequestered by
the intracellular store via the SERCA pump, sustained oscillatory activity
will have an obligatory requirement for inﬂux of extracellular Ca21, so
the intracellular oscillator is intimately coupled with Ca21 ﬂuxes across the
plasma membrane. Cytochemical evidence indicates that the RyR and the
InsP3R are both present on the SR of vascular myocytes and distributed
throughout their cytoplasm (22–24). Although the spatial overlap of RyR-
and InsP3R-gated stores may not always be complete (25), for simplicity we
have assumed that they mediate CICR from a common intracellular Ca21
store. This allows the development of a 1-pool, 2-receptor representation of
the intracellular Ca21 oscillator that can be described mathematically by just
two variables, namely [Ca21] in the cytosol and [Ca21] in the lumen of the
common store (x and y, respectively, in Eqs. 1 and 2).
Three RyR subtypes are expressed in vascular smooth muscle (22,26) and
each subtype exhibits low-afﬁnity inhibition by Ca21 such that RyR1
channels closewhen [Ca21] approaches 1mM, andRyR2 andRyR3 channels
close when [Ca21] is in the range 1–10 mM (27,28). Since such Ca21
concentrations may be supraphysiological, even in localized intracellular
domains, the extent to which Ca21-dependent inactivation of the receptor by
cytosolic Ca21 serves as a negative control mechanism that contributes to the
termination of RyR-mediated CICR is unclear. Consequently, in formulating
the model it was assumed that there is a negligible fall off in the open
probability of the receptor at [Ca21] levels within the physiological range.
Activation of the RyR by Ca21 occurs within;1 ms, and the channel rapidly
turns off (i.e., deactivates) with a time constant of 5–6 ms in response to fast
reductions in [Ca21] (27). The RyR also exhibits a so-called ‘‘adaptive’’
inactivation to elevations in [Ca21] that allows subsequent increases in
[Ca21] to elicit nearly identical increases in open probability (27), and in the
case of RyR2 such adaptation occurs within milliseconds in the presence of
physiological concentrations of the Mg21 ion (29). Since the kinetics of the
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RyR is rapid compared to the timescale of vasomotion (i.e., seconds to
minutes (1)), it was assumed that its open probability is dominated by
instantaneous activation and deactivation, and time-dependent inactivation
and adaptation of the receptor were not speciﬁcally incorporated in themodel.
Based on arguments outlined in the literature (30–32), the steady-state [Ca21]
dependence of the RyRwas generallymodeled as a monotonically increasing
fourth-order Hill sigmoidal (Fig. 1 A). This is consistent with the tetrameric
nature of the RyR protein, although it should be noted that under different
experimental conditions the degree of cooperativity implied by the Hill
coefﬁcient can lie between 2 and 7 (28,33,34). In some simulations, therefore,
the value of this coefﬁcient was varied systematically to assess its dynamical
role. Ca21 concentrations resulting in half-maximal activation of the RyR
were varied between 0.2 and 0.9 mM to encompass the range of values
reported in the literature (27,28,33). No attempt was made to allow for
differences in the gating characteristics of the three RyR subtypes or spatial
heterogeneity in their possible subcellular location (22,26).
Three InsP3R subtypes have been identiﬁed in vascular smooth muscle
cells and are generally reported to exhibit biphasic steady-state activation
curves as a function of [Ca21] under different experimental conditions
(24,35–38). In superfusion studies with isolated microsomes, the peak
InsP3R open probability attained after elevations in [Ca
21] decreases to a
steady plateau over 0.5–2 s through Ca21-dependent and Ca21-independent
inactivation mechanisms that remain poorly understood (39). Indeed,
although some studies have suggested that Ca21-sensitive binding of
calmodulin to the InsP3R facilitates closure of the channel, the InsP3R3 has
been reported to exhibit a biphasic activation curve despite the lack of a
calmodulin binding domain in this speciﬁc subtype (40). The InsP3R also
‘‘adapts’’ to submaximal concentrations of InsP3 that evoke transient rather
than continuous Ca21 release, in the sense that subsequent increments in
[InsP3] are capable of eliciting further Ca
21-release transients (41). Complex
kinetic binding models have been devised to simulate the characteristics of
time-dependent inactivation and adaptation of the InsP3R (41,42). However,
Li and Rinzel (43) were able to capture the essential dynamical features of
this approach by formulating a reduced two-variable model in which a fast
variable described Ca21 release and a slow variable described time-
dependent inactivation of the InsP3R. Hofer (44) further simpliﬁed this
scenario by adopting a quasi-steady-state approximation that removed the
necessity for a dynamic inactivation variable in hepatocytes, a cell type in
which the oscillation period is longer than the time constant for InsP3R
inactivation and ranges from 30 s at maximal levels of stimulation to several
minutes for low agonist doses. For the purposes of this study, therefore,
activation and deactivation of the InsP3R by Ca
21 ions were assumed to be
instantaneous, and time-dependent inactivation and adaptation of the InsP3R
were not incorporated in the model because they generally occur on a
timescale faster than that of vasomotion, as noted above. This approach is
also consistent with experimental evidence that photolytically induced
elevations in [Ca21] up to ;150 nM cause an immediate potentiation of
Ca21 release in permeabilized smooth muscle cells, whereas larger Ca21
jumps (in the range 250–850 nM) cause immediate (rather than delayed)
slowing of Ca21 release (45).
The dominant InsP3R subtype present in the smooth muscle of the rat
basilar artery is InsP3R1, with much lower expression of InsP3R2 and no
expression of InsP3R3 (24). Empirically, Mak and co-workers (37) found
that the quasisteady open probability of InsP3R1 channels could be ﬁtted to a
dual sigmoidal Hill function that was hypothesized to reﬂect the existence of
activating sites with a Hill coefﬁcient of 2 and inhibitory sites with a Hill
coefﬁcient of 4, thus suggesting that activation and inhibition of the
tetrameric InsP3R by Ca
21 are both cooperative events, requiring binding of
Ca21 ions to two monomers to promote channel opening and binding of
Ca21 to all four components to inhibit channel opening. Subsequent reports
have employed an analogous approach to model the quasisteady Ca21
sensitivities of a variety of InsP3R subtypes (including chimeric constructs),
and have reported activating coefﬁcients in the range 1–4 and inactivating
coefﬁcients in the range 1–3 (36,38). In this study, dual Hill sigmoidals were
used to generate biphasic open probability curves that allow the coefﬁcients
of their activation and deactivation components to be varied independently.
The positions of the curves could thus be manipulated to encompass
experimental evidence that the Ca21 concentrations resulting in 50%
activation or inactivation of the InsP3R channel may lie between 30 nM and
1 mM and between 200 nM and 50 mM, respectively, with corresponding
peak values lying in the range 100 nM to 1 mM (36–38) (Fig. 1 B). In intact
cells, the shape and position of the these curves will be inﬂuenced by [InsP3]
and [ATP], which can increase sensitivity to Ca21 and/or remove inhibition
by high [Ca21]i (36,42), but levels of these factors could not be manipulated
experimentally, since all vessels exhibited spontaneous vasomotion.
In previous theoretical studies, the driving force for CICR (via the RyR or
the InsP3R) has often been modeled as the concentration gradient between
[Ca21] in the store and the cytosol. However, there is evidence that store
depletion itself contributes to the termination of Ca21 release via both the
RyR (31,46,47) and the InsP3R (41,48,49). More speciﬁcally, it has been
hypothesized that inhibition of the InsP3R observed when store [Ca
21] is
low reﬂects the binding of regulatory intraluminal proteins such as ERp44 to
the receptor. Thus, the interaction of this protein with InsP3R1 is weak when
store [Ca21] exceeds 100 mM, providing a mechanism whereby binding of
ERp44 to the receptor could actively diminish Ca21 release (50). Since the
open probabilities of the RyR and InsP3R may thus both decrease when store
[Ca21] is low, a nonlinear fall-off in CICR as store [Ca21] declines was
implicitly incorporated in this model as a sigmoidal function of store [Ca21].
FIGURE 1 Nonscaled steady-state
open probability curves. (A) The RyR
curves are fourth-order Hill sigmoidals
whose sensitivity to Ca21 is governed
by the coefﬁcient xr, which deﬁnes the
concentration producing half-maximal
activation of the channel. (B) Sample
InsP3R curves plotted for three values of
the half-point of the activation sigmoidal
(xi) and three values for the half-point
for the inactivation sigmoidal (hi). The
Hill coefﬁcient for both sigmoidals was
selected as 4. Parameters were selected
to encompass the range of positions of
the RyR and InsP3R curves reported in
the literature (see text). In general, the
maximum open-state probability of the
channelsmaybe,1,but this is accounted
for by the scaling coefﬁcients Cr and Ci.
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The Hill coefﬁcient for this mechanism was generally taken as 4, although
the effects of other values were also investigated. Uptake of Ca21 by the
store via the SERCA pump was modeled as a second-order Hill sigmoidal in
all simulations, consistent with experimental data (51).
In open cell systems based on CICR, sustained oscillations in Ca21
require an inward ﬂux of extracellular Ca21 into the cytosol to compensate
for loss of Ca21, e.g., via the plasmalemmal Ca21 ATPase and forward-
mode Na1-Ca21 exchange (NCX). In the open model described in this
article, such inﬂux is provided via Ca21-permeable nonselective cation
channels (NSCCs), voltage-operated Ca21 channels (VOCCs) and reverse-
mode NCX. Recent experimental evidence suggests that NSCCs are
constructed from transient receptor potential proteins, and are constitutively
active in vascular myocytes, so they may contribute to resting membrane
conductance and basal Ca21 inﬂux, in addition to being activated by vaso-
constrictor agonists, depletion of Ca21 stores, and mechanical stretch (52).
Since NSCCs are gated by diacylglycerol (DAG), via both protein kinase
C-dependent and -independent mechanisms (52), a critical determinant of
vasomotion may therefore be the mobilization of Ca21 by phospholipase C
(PLC), since this enzyme underpins the formation of both DAG and InsP3
and may therefore simultaneously regulate extracellular Ca21 inﬂux and
Ca21 release from stores via the InsP3R (53).
The third variable incorporated in the model is membrane potential (z in
Eq. 3), with inﬂux of Ca21 ions via VOCCs being promoted by mem-
brane depolarization. Membrane potential is also inﬂuenced by the balance
between K1 and Cl movements, which compete to drive cell potential
toward their respective reversal potentials at approximately 95 and 25
mV, and by NCX, depending on whether the exchanger operates in forward
or reverse mode. To simplify computation, the quasisteady open probability
of these electrogenic membrane ion transport systems was assumed to
govern their contribution to membrane potential. This approach differs from
a previous model of arterial vasomotion in which the open-state probability
of K1 channels was assigned the status of an independent dynamical vari-
able that exhibited time-dependent inactivation (17).
The third-order system of coupled nonlinear differential equations describ-
ing this open system assumes the following form:
The reversal potential of the Na1-Ca21 exchange mechanism is [Ca21]i-
dependent and can be calculated as zNa/Ca¼ 3zNa 2zCa1, where the reversal
potentials zCa1 and zNa are derived from the Nernst equation according to
zCa1 ¼ ðRTÞ=ðFZCaÞlnð½Ca21oÞ=ð½Ca21iÞ and zNa ¼ ðRTÞ=ðFZNaÞ
lnð½Na1oÞ=ð½Na1iÞ with ZNa ¼ 1, ZCa ¼ 2, and ðRTÞ= ðFÞ ¼ 0:024
(R, gas constant; F, Faraday’s constant, T ¼ 310K). It was assumed that
[Ca21]o¼ 2.5 mM and ð3RTÞ=ðFZNaÞlnð½Na1oÞ= ð½Na1iÞ ¼ 0:207:
The coefﬁcient g represents a scaling factor that determines the rate at
which ionic currents modulate variations in membrane potential (17).
Realistic responses that matched experimental data were obtained by ﬁxing
the value of g at 1 V/mM throughout the study. Ca21 ions in the cytosol and
Cytosolic free Ca21:
dx
dt
¼ A GCa z zCa1
11 eðzzCa2 Þ=RCa
1GNa=Ca
x
x1 xNa=Ca
ðz zNa=CaÞ  B x
n
x
n1 xnb
Ca21 influx Ca21 influx NCX SR uptake
via NSCC via VOCC
1Cr
ymr
y
mr 1 ymrr
xpr
x
pr 1 xprr
1 Ci
ymi
y
mi 1 ymii
xpi
x
pi 1 xpii
1 x
qi
x
qi 1 hqii
 
CICR via RyR CICR via InsP3R
 Dxk 11 z zd
Rd
 
1 Ly
Ca
21
extrusion SR leak (1)
[Ca21] in the sarcoplasmic reticulum:
dy
dt
¼ B x
n
xn1 xnb
 Cr y
mr
ymr 1 ymrr
xpr
xpr 1 xprr
 Ci y
mi
ymi 1 ymii
xpi
xpi 1 xpii
1 x
qi
xqi 1 hqii
 
Ly
SR uptake CICR via RyR CICR via InsP3R SR leak
(2)
Relationship between membrane ion ﬂuxes and cell potential:
dz
dt
¼ g

 GCl x
x1 xCl
ðz zClÞ  2GCa z zCa1
11 eðzzCa2 Þ=RCa

Cl channels Ca
21
influx via VOCC
 GNa=Ca x
x1 xNa=Ca
ðz zNa=CaÞ  GKðz zKÞ x
x1beðzzCa3 Þ=RK

NCX K
1
efflux
(3)
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the SR are bound by intracellular proteins to different extents, so for the
purposes of modeling it is necessary to deﬁne ‘‘effective volumes’’ that are
distinct from the physical volumes of the cytosol and the SR. As argued in
Parthimos et al. (17), the effective volumes of the two compartments are
closely similar, thus permitting the assumption that Ca21 concentration
changes in the cytosol and stores are directly related, as is implicit in Eqs.
1 and 2.
Insights into the contribution of CICR via the RyR and InsP3R to the
dynamics of the model were obtained by plotting the x and y nullclines, i.e.,
the loci of points at which the rates of change of [Ca21]i and [Ca
21]SR are
both zero under different parametric conditions. Standard stability theory
indicates that oscillations occur only when the eigenvalues that characterize
the deformation of the phase space in the neighborhood of the crossing of
these nullclines are complex conjugates with a positive real part, and for the
generic form of the nullclines generated by Eqs. 1 and 2 this condition
requires that both exhibit a negative slope at the point of intersection (17).
The limit cycle oscillation that emerges around the unstable equilibrium
point then exhibits three distinct phases. These include a section that
determines the amplitude of the oscillatory behavior and in which CICR
causes rapid emptying of the SR Ca21store leading to an abrupt rise in
[Ca21]i and fall in [Ca
21]SR. This is followed by a section in which Ca
21
ions are extruded from the cell more rapidly than they enter from the
extracellular space, so that [Ca21]i declines and [Ca
21]SR remains low.
Eventually, however, inﬂux of Ca21 dominates over extrusion, allowing
sequestration of Ca21 entering the cell within the SR store, with [Ca21]i
remaining almost constant. Store reﬁlling continues until the driving force
for CICR once again increases to the point where regenerative Ca21 release
is able to initiate another cycle (17,30). The overall period of the resulting
oscillatory behavior is governed by the duration of store reﬁlling, since this
is slow compared to the other two components of the cycle.
Numerical methods
Simulations were produced by numerical integration with the Runge-
Kutta-Merson algorithm, employing an integration step in the range of
0.0005–0.003 s. Physiological values for ﬁxed coefﬁcients employed in the
simulations were taken from Parthimos et al. (17) and are provided in Table 1.
Pharmacological interventions were simulated by altering the appropriate
coefﬁcient(s) in Eqs. 1–3 in a stepwise fashion according to the ion transport
system under study, as indicated in the corresponding ﬁgure or ﬁgure legend.
RESULTS
Control responses
Spontaneous oscillations in the membrane potential of the rat
basilar artery and its primary branches were of the order of
5–15 mV, generally falling within the membrane potential
range –30 to –45 mV, with oscillations in diameter being
5–10% of mean.
Role of CICR
Effects of ryanodine
Ryanodine has variously been reported to promote opening
of the RyR channel with preserved or decreased single-
channel conductance, to increase the Ca21 sensitivity of the
channel, to lock the channel in an open subconductance state,
or to cause complete channel closure (28,54,55). These
effects of ryanodine were simulated with Ci set to zero (i.e.,
in the absence of InsP3R-mediated Ca
21 release) as follows:
1. Increases in the coefﬁcient Cr were used to scale the
single-channel open-probability curve and thus increase
Ca21 ﬂux from the SR store (i.e., number of RyR
channels 3 channel conductance 3 open probability).
This strategy resulted in a decrease in the amplitude of
oscillations in membrane potential and [Ca21]i and an
increase in oscillation frequency. There was little effect
on the mean values of membrane potential and [Ca21]i
(Fig. 2 A).
2. Decreases in the coefﬁcient xr were used to mimic the
enhanced Ca21 sensitivity of the RyR activation sigmoi-
dal reported with low concentrations of ryanodine. This
strategy will increase Ca21 ﬂux from the SR store via the
RyR and, as in scenario 1, revealed a reciprocal rela-
tionship between the amplitude and frequency of oscil-
lations in membrane potential and [Ca21]i, but no major
change in their mean values (Fig. 2 B).
3. Increases in the leak coefﬁcient L to simulate the for-
mation of the locked-open subconductance state decreased
the amplitude of rhythmic activity without affecting os-
cillation frequency (Fig. 2 C).
4. Decreases in coefﬁcient Cr to mimic the closure of the
RyR reported with high micromolar concentrations of
ryanodine resulted in an increase in oscillation ampli-
tude and an associated decrease in frequency (Fig. 2 D).
Mathematically, this is the converse of scenario 1.
Experimentally, 10 mM ryanodine reduced the amplitude
of rhythmic activity with little effect onmean diameter, mem-
brane potential, wall [Ca21]i, or [Ca
21]i in individual smooth-
muscle cells (Fig. 2, E–G). Since this action of ryanodine
was generally associated with an increase in oscillation fre-
quency, it follows that the observed effects of ryanodine in
the rat basilar artery were most closely modeled by increas-
ing the Ca21 ﬂux via the RyR as in scenarios 1 and 2 above.
Detailed insights into the dynamics of the CICR mech-
anism were obtained by nullcline analysis in which two-
dimensional plots of x against y were generated with the
value of z held constant at 40 mV. On increasing Cr or
reducing xr, the intersection of x and y nullclines translated
downward with a progressive decrease in the size of the limit
cycle encircling the unstable equilibrium point (Fig. 3, A and
B). Conversely, the decreases in Cr that model channel
closure increased the size of the limit cycle (Fig. 3 A).
Oscillatory behavior ceased for extreme values of Cr or xr,
where the equilibrium point became stable. Increases in L
had a relatively small effect on the position of the inter-
section of the x and y nullclines (Fig. 3 C). Consequently, the
duration of the slow SR reﬁlling phase of the limit cycle, and
thus oscillation frequency, was not strongly dependent on L,
whereas the amplitude of the oscillation decreased as the fast
emptying phase of the limit cycle became abbreviated for
high values of L. The general relationship between the am-
plitude and frequency of vasomotion during these different
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approaches to simulation was explored systematically (Fig.
3 D). It can be seen that the inverse relationship between
amplitude and frequency observed during variations in Cr is
approximately linear for small values of L (encompassing the
range used in all simulations), but that this linearity breaks
down for high values of L. In contrast, increases in L result in
the gradual suppression of oscillatory activity, with minimal
effects on oscillation frequency (at least for the range of
values used in the simulations). The effect of variations of xr
(also illustrated in Fig. 3 D) demonstrates an inverse linear
relationship between amplitude and frequency analogous to
that observed for variations of Cr.
Nullcline analysis was also used to deﬁne the role of the
RyR-activation Hill coefﬁcient pr and the Ca
21-release Hill
coefﬁcient mr in the genesis of oscillatory behavior. De-
creases in pr translated the intersection of the x and y nullclines
downward, reducing the size of the associated limit cycle and
its period and amplitude, until oscillatory behavior ceased
when pr fell below;3 (Fig. 4 A). By contrast, the position of
the nullcline intersection was relatively insensitive to changes
in mr, so that oscillatory activity was sustained at low values
of this parameter (Fig. 4 B). However, high values of mr
resulted in rapid saturation of the Ca21-release mechanism
and less complete emptying of the SR store, thus causing an
elevation of the nullclines, i.e., increased [Ca21]SR for a
given level of [Ca21]i. This was associated with a reduction
in oscillation amplitude and a decrease in the slow reﬁlling
period necessary to replenish stores, so that oscillation
frequency was increased.
InsP3R-mediated CICR
The kinetics of InsP3R-mediated Ca
21 release was modeled
with a dual Hill sigmoidal. At [Ca21]i levels ,1 mM, the
conﬁguration of the x and y nullclines was closely similar
to that of the RyR channel. Indeed, in the absence of
complicating RyR activity (i.e., Cr set to zero), simulations
TABLE 1 Table of coefﬁcients
Parameter Description Value (unless otherwise stated)
A Ca21 inﬂux via NSCCs. Simulations, 2.3 mM/s
Nullcline analysis 0.7 mM/s
GCa whole-cell conductance for voltage-operated Ca
21 channels 12 mM/V s
zCa1 reversal potential for VOCC 120–135 mV
zCa2 half point of the VOCC activation sigmoidal 24 mV
RCa maximum slope of the VOCC activation sigmoidal 8.5 mV
GNa/Ca whole-cell conductance for NCX 43.8 mM/V s
xNa/Ca half-point for activation of NCX by Ca
21 0.5 mM
zNa/Ca reversal potential for NCX 30 to 45 mV
B SR uptake rate constant 400 mM s1
xb half-point of the SR ATPase activation sigmoidal 4.4 mM
n Hill coefﬁcient for x dependence of SR uptake 2
Cr Ca
21-induced Ca21 release rate constant for RyR 1250 mM s1
Ci Ca
21-induced Ca21 release rate constant for InsP3R 0 mM s
1
yr half-point of the CICR via RyR Ca
21 efﬂux sigmoidal 8.9 mM
xr half-point of the RyR CICR activation sigmoidal 0.9 mM
pr Hill coefﬁcient for x dependence of CICR via RyR 4
mr Hill coefﬁcient for y dependence of CICR via RyR 2
yi half-point of the CICR via InsP3R Ca
21 efﬂux sigmoidal 8.9 mM
xi half-point of the InsP3R CICR activation sigmoidal 0.03–0.9 mM
pi activation Hill coefﬁcient for x dependence of CICR via InsP3R 4
mi Hill coefﬁcient for y dependence of CICR via InsP3R 2
hi half-point of the InsP3R CICR inactivation sigmoidal 1.0–20 mM
qi inactivation Hill coefﬁcient for x dependence of CICR via InsP3R 4
D rate constant for Ca21 extrusion by the ATPase pump 6.25 mM1 s1
k exponent for x dependence of Ca21 extrusion 2
zd intercept of voltage dependence of extrusion ATPase 100 mV
Rd slope of voltage dependence of extrusion ATPase 250 mV
L leak from SR rate constant 0.025 s1
g scaling factor relating net movement of ion ﬂuxes to membrane
voltage (inversely related to cell capacitance)
1 V/mM
GCl whole-cell conductance for Cl
 current 65 mM/V s
zCl reversal potential for Cl
 channels 25 mV
xCl Ca
21 sensitivity of Cl channels 0 mM
GK whole-cell conductance for K
1 efﬂux 43 mM/V s
zK reversal potential for K
1 95 mV
b Ca21 sensitivity of KCa channel activation sigmoidal 0 mM
zCa3 half-point for the KCa channel activation sigmoidal 27 mV
RK maximum slope of the KCa activation sigmoidal 12 mV
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FIGURE 2 Four approaches simulating the reported actions of ryanodine by changing coefﬁcients in Eqs. 1 and 2. (A) Increases in Cr from 1250 to 3250. (B)
Decreases in the Ca21 sensitivity coefﬁcient xc from 0.9 to 0.6. (C) Increases in L from 0.025 to 0.15. (D) Reductions in Cr from 1250 to 500. (E–G)
Experimentally, ryanodine increased oscillatory frequency in association with a reduction in the amplitude of oscillations in diameter, membrane potential,
global wall [Ca21], and [Ca21] in individual smooth muscle cells (SMC), but had little effect on their average values.
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demonstrated that increases in the coefﬁcient Ci to scale the
ﬂux of Ca21 ions via the InsP3R channel or decreases in the
coefﬁcient xi to enhance the Ca
21 sensitivity of the activating
component of the biphasic open probability curve each re-
duced the size of the limit cycle and ultimately stopped
oscillatory activity (Fig. 5, A and B). Compared to the RyR,
the position of the nullclines relative to the y axis were ele-
vated by the inactivating component of the InsP3R dynamics
at [Ca21]i levels .1 mM, since InsP3R closure will curtail
Ca21 release above this level. Consequently, decreases in the
inactivating coefﬁcient hi of the dual InsP3R Hill sigmoidal,
which result in a leftward shift in the peak of the open prob-
ability curve of the InsP3R channel (Fig. 1), reduced the size
of the limit cycle by progressively abbreviating the Ca21-
release phase of the oscillatory mechanism (Fig. 5 C).
As in the case of the RyR dynamics, oscillations were
observed only when the activating Hill slope pi was above
;3 and the Hill exponent for Ca21 release mi inﬂuenced the
size of the underlying limit cycle but did not determine the
existence of oscillations (Fig. 6 A andB). The overall dynamics
of the system was largely insensitive to changes in the
secondary inactivating Hill slope qi (Fig. 6 C).
Interactions between the RyR and InsP3R
A value of Ci was selected so that the system was in a
nonoscillatory regime and the value of Cr progressively
increased, with the activation Hill coefﬁcients of both
channels taken as 4. This strategy allowed the emergence
of oscillatory behavior, which ultimately ceased when the
intersection of the x and y nullclines regained stability. As the
FIGURE 3 Nullcline analysis of the
putative actions of ryanodine. (A–C)
Pairs of nullclines and corresponding
limit cycles for changes in parameters
Cr, xc, and L. The intersection of the x
(dashed line) and y (solid line) null-
clines determines the equilibrium
points indicated by an open circle
when unstable (i.e., oscillatory) and a
solid circle when stable (nonoscilla-
tory). In each case, progressive de-
creases in the coefﬁcient under
investigation ultimately suppressed os-
cillatory behavior. (D) Effects of these
interventions on oscillation frequency
and amplitude.
FIGURE 4 Effects of changes in the
RyR Hill coefﬁcients pr and mr. (A)
Graded reductions in the activation
coefﬁcient pr from 4 to 2 reduced the
size of the limit cycle until oscillatory
behavior ceased. (B) Reductions in the
Ca21 release coefﬁcient mr progres-
sively increased the size of the limit
cycle but did not stop oscillations.
Dashed and solid lines denote the x
and y nullclines; open and solid circles
denote unstable and stable equilibrium
points.
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contribution of the RyR to the dynamics of the system was
increased, the conﬁguration of the nullclines progressively
diverged from that associated with the InsP3R at [Ca
21]i
levels .1 mM, i.e., it changed from convex-up to ﬂat. The
overall effect was to translate the limit cycle downward as
levels of [Ca21]SR decreased, but in contrast to the situation
for the RyR alone, this translation was associated with a
selective reduction in the store reﬁlling phase of the limit
cycle so that the amplitude of [Ca21]i oscillations remained
effectively constant as their frequency increased (Fig. 7 A).
An analogous simulation was performed with a value of Cr
selected such that the system did not exhibit oscillations and
the value of Ci progressively increased. Again this resulted in
the emergence of an unstable nullcline intersection point that
eventually regained stability. In this scenario, the limit cycle
was translated downward but became globally smaller, with
reduced amplitude and period, until it disappeared (Fig. 7 B).
The nullcline analysis shown in Fig. 7, A and B, was
performed with z held at –40 mV; attractors generated by
simulations in which membrane potential z contributed to the
dynamics as an independent variable (i.e., by the full three-
dimensional model of Eqs. 1–3) illustrate similar general
behavior (Fig. 7, C and D).
The mathematical structure of the model necessarily
implies that CICR mediated either by the RyR and/or
the InsP3R will not be a principal determinant of mean
[Ca21]i. This can be appreciated by equating dx/dt and dy/dt
to zero to deﬁne the unstable equilibrium point around which
intracellular Ca21 oscillations develop. Addition of Eqs.
1 and 2 then gives
AGCa z zCa1
11eðzzCa2 Þ=RCa
1 GNa=Ca
x

x
1xNa=Ca
ðz zNa=CaÞ
Dxk 11 z zd
Rd
 
¼ 0: (4)
It follows that x*, the equilibrium value of [Ca21]i, is
independent of Cr, Ci, B, and L and also the Hill coefﬁcients
of the RyR and InsP3R sigmoidals. This idea gains support
from the experimental ﬁnding that ryanodine did not
signiﬁcantly affect mean values of wall [Ca21]i or [Ca
21]i
in individual smooth muscle cells in the rat basilar artery
(Fig. 2). It should be noted, however, that x* provides only a
guide to the mean value of [Ca21]i when the dynamics of the
system support the existence of a limit cycle, since x* will be
FIGURE 5 Nullcline analysis of the dynamics of InsP3R-mediated CICR. (A–C) Pairs of nullclines and corresponding limit cycles for different values of the
open probability coefﬁcient Ci, activation sensitivity xi and inactivation half-point hi. Dashed and continuous lines denote the x and y nullclines; open and
solid circles denote unstable and stable equilibrium points.
FIGURE 6 Nullcline analysis for the activating and inactivating InsP3R Hill coefﬁcients. Plots are shown for (A) the activation coefﬁcient pi,, (B) the store
release coefﬁcient mi, and (C) the inactivation coefﬁcient qi. Dashed and solid lines denote the x and y nullclines; open and solid circles denote unstable and
stable equilibrium points.
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dependent on cell membrane potential. Indeed, as noted
above, all nullcline analysis was performed with a constant z
to eliminate the effect of the membrane potential on the
dynamics of the system and maintain a strictly two-
dimensional oscillatory regime that allows clear visualiza-
tion of the effects of speciﬁc parameter changes. To evaluate
the consequences of this simpliﬁcation, the dependence of
the equilibrium values x* on z was quantiﬁed by using Eq. 4
to plot x* as a function of z (Fig. 7 B, inset). The plot
demonstrates that for a broad range of z values within the
physiological range (70 to20 mV) there was only a small
impact on x* (,0.1 mM).
Role of membrane transport systems
In all simulations designed to investigate the contribution of
transmembrane ion ﬂuxes to vasomotion, Cr was assigned
the same initial default value with the coefﬁcient Ci set to
zero. Although this computational simpliﬁcation implies that
InsP3R activity does not participate in intracellular Ca
21
dynamics, it should be appreciated from the above analysis
that general conclusions concerning the role of different
membrane transport systems will not differ whether CICR is
modeled mathematically as an RyR- or InsP3R-dependent
process within the physiological operating range for [Ca21]i.
Calcium inﬂux via NSCCs
The PLC inhibitor U73122 will attenuate inﬂux of extracel-
lular Ca21 ions into the cytosol via NSCCs by depressing the
formation of DAG, and the contribution of this mechanism to
vasomotion was investigated by reducing the coefﬁcient A in
Eq. 1. Such simulations resulted inmembrane hyperpolarization,
a reduction in mean [Ca21]i, and complete suppression of os-
cillatory activity (Fig. 8 A). Experimentally, closely analogous
effects on membrane potential and [Ca21]i were observed
after administration of 10mMU73122, which caused dilatation
and abolished rhythmic activity in rat isolated basilar arteries
(Fig. 8, B–D). Taken together, these theoretical and exper-
imental ﬁndings demonstrate the crucial role of Ca21 inﬂux
in the maintenance of rhythmic activity and suggest that the
pharmacological action of U73122 is dominated by its
effects on DAG formation rather than InsP3 synthesis.
Calcium inﬂux via VOCCs
The action of the VOCC blocker nifedipine was simulated by
reducing the coefﬁcient GCa in Eqs. 1 and 3 (Fig. 9). In
general, this strategy tended to cause slight membrane hy-
perpolarization and a decrease in [Ca21]i, although the
effects of reductions in GCa on the amplitude of oscillatory
activity depended on the magnitude of the ﬂux of Ca21 ions
into the cytosol via NSCCs relative to that entering via
VOCCs. When DAG-mediated Ca21 inﬂux via NSCCs (co-
efﬁcient A in Eq. 1) was high, oscillations persisted even
when blockade of VOCCs was complete (Fig. 9 A). By
contrast, when this Ca21 inﬂux via NSCCs was less domi-
nant (i.e., A was low), suppression of the inward Ca21
current via VOCCs resulted in complete loss of oscillatory
activity (Fig. 9 B). Experimentally, 1mMnifedipine suppressed
oscillations in membrane potential, wall calcium, and vessel
FIGURE 7 Analysis of combined
RyR- and InsP3R-mediated CICR. (A)
Progressive activation of Ca21 release
by ryanodine (simulated as an increase
in Cr) in the presence of ﬁxed InsP3-
mediated CICR (constant Ci) can initi-
ate or suppress oscillatory activity. (B)
Similar analysis for progressive in-
creases in coefﬁcient Ci for ﬁxed Cr.
(C andD) Two-dimensional projections
of the full three-dimensional attractor of
the dynamics. Increases in coefﬁcients
Cr and Ci translate the attractors in the
direction of the arrows. The inset in B
illustrates the relationship between the
equilibrium values [Ca21]i (x*) and
membrane potential (z*) as a solution
of Eq. 4. Dashed and solid lines denote
the x and y nullclines; open and solid
circles denote unstable and stable equi-
librium points. Nullclines and limit
cycles were obtained with z held at
40 mV; attractors were generated
from trajectories where z was a free
variable.
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diameter, as predicted by the simulations (Fig. 9, C–E).
These ﬁndings further emphasize the role of extracellular
Ca21 inﬂux in the genesis of vasomotion.
Bifurcation analysis of Ca21 inﬂux
To clarify the dynamical connection between Ca21 ﬂuxes via
VOCCs and NSCCs, a bifurcation diagram for [Ca21]i
oscillations was constructed for variations in the control
parameters GCa and A (Fig. 10 A). Decreases in GCa ﬁrst
produced a Hopf bifurcation into an oscillatory regime, but
oscillations were subsequently suppressed via the reverse
Hopf scenario, when Ca21 uptake via VOCCs was further
reduced. For large values of A, the oscillatory regime was
maintained throughout the physiological range of GCa (i.e.,
GCa$ 0). Ca
21 ﬂux via NSCCs (i.e., coefﬁcient A) therefore
represents a control parameter that determines whether os-
cillatory activity will be abolished or sustained during com-
plete blockade of VOCCs. The transition between these cases
(corresponding to low and high NSCC ﬂuxes) is also pre-
sented as time series in Fig. 10 B.
The interplay between extracellular Ca21 inﬂux viaNSCCs
and VOCCs and RyR-mediated intracellular Ca21 release
was also investigated by nullcline analysis of the effects of
variations in the coefﬁcients A, GCa, and Cr. This analysis
illustrates how low and high levels of inﬂux via either channel
generally lead to the loss of oscillatory activity, although there
is also a crucial dependence on Cr (Fig. 11, A and B).
Effects of charybdotoxin
The effects of the Ca21-activated K1 channel (KCa) inhibitor
charybdotoxin were simulated by reducing the coefﬁcient
GK in Eq. 3 (Fig. 12 A). This strategy induced membrane
depolarization, elevated mean [Ca21]i, and reduced the
amplitude of oscillations in these variables in association
with an increase in their frequency (Fig. 12 A). Experimen-
tally, 60 nM charybdotoxin depolarized the smooth muscle
of the rat basilar artery and increased both wall and cell
[Ca21]i in association with constriction (Fig. 12, B–D). In the
example shown, the reduction in amplitude (;80%) and the
increase in frequency (;50%) were of the same order of
magnitude as the simulations illustrated in Fig. 12 A.
Role of chloride channels
The role of chloride channels was probed with two alter-
native strategies: 1), substitution of extracellular chloride
ions to enhance Cl extrusion; and 2), direct pharmacolog-
ical blockade of Cl channels.
1. Stepwise changes in [Cl]o were modeled as a dis-
crete shift in the operating Cl reversal potential af-
ter the introduction of a 17-mV DzCl step in the
voltage dependence of the Cl channel in Eq. 3, i.e.,
GClðx=ðx1 xClÞÞðz ðzCl1DzClÞÞ: This approach re-
sulted in a membrane depolarization of;10 mV that was
accompanied by an increase in [Ca21]i and loss of
rhythmic activity (Fig. 13 A). Experimentally, the effects
of chloride substitution with 120 mM sodium isethionate
closely matched these simulations, showing a marked de-
polarization and increase in [Ca21]i in association with
sustained constriction (Fig. 13, B–D).
2. Pharmacological interventions with the Cl channel
blocker niﬂumic acid were simulated by reducing the
coefﬁcient GCl in Eq. 3. This suppressed oscillatory
FIGURE 8 (A) Reductions in term A of Eq. 1 were used
to simulate the action of U73122 (from A ¼ 2.3 to A ¼
0.0). (B) Experimentally, 10 mM U73122 caused mem-
brane hyperpolarization, dilatation and loss of rhythmic
activity. (C and D) 10 mM U73122 also inhibited
oscillations in global wall [Ca21] and cytosolic [Ca21]i
in individual smooth muscle cells.
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activity completely in association with membrane hyper-
polarization (Fig. 13 E). Experimental ﬁndings with 50
mM niﬂumic acid closely matched these theoretical
predictions (Fig. 13, F–H).
Integrated behavior of membrane
transport systems
The contributions of K1 efﬂux, Na1/Ca21 exchange, Cl
channels, and Ca21 inﬂux through VOCCs to dynamic changes
in membrane potential (dz/dt) are plotted as a function of
membrane potential in Fig. 14 A, with the ordinate showing
the individual and summed effects of these transport
systems. The composite dz/dt curve intersects the horizontal
axis at three points, which represent possible steady states
where oscillations in membrane potential and [Ca21]i may
be abolished, with the central equilibrium point (P2) unstable
but the outer points (P1 and P3) stable. Families of dz/dt plots
were calculated from Eq. 3 to gain insight into the actions of
the pharmacological probes as follows:
1. Each of the plots presented in Fig. 14 B corresponds to a
single value of [Ca21]i between 0.1 and 0.9 mM, and it
can be seen that reductions in [Ca21]i translate the P1
stable equilibrium to the left and thereby promote
hyperpolarization. Although the effects of [Ca21]i on
dz/dt are viewed at constant values of [Ca21]i, and
therefore do not reproduce the dynamics of Eqs. 1–3
under oscillatory conditions, such plots provide insight
into the behavior of the system after administration of the
PLC inhibitor U73122, which will reduce time-averaged
FIGURE 9 (A and B) Reductions in
the coefﬁcientGCa of the VOCC term in
Eqs. 1 and 3 from 12 to 0 were used to
simulate the action of nifedipine. When
coefﬁcient A was relatively large (2.3
(A)) blockade of VOCCs did not sup-
press oscillatory activity, whereas for
small values of A (0.7 (B)) oscillations
were abolished. (C–E) Experimentally,
1 mM nifedipine effectively abolished
vasomotion with oscillations in wall
[Ca21] and in individual smooth muscle
cells being markedly reduced in ampli-
tude.
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[Ca21]i by suppressing the net inﬂux of Ca
21 ions via
NSCCs into the cytosol.
2. Reductions in GCa to simulate blockade of VOCCs result
in a depression of the bell-shaped maximum in dz/dt at
membrane potentials close to 0 mV with a leftward shift
in the P1 stable equilibrium and hyperpolarization (Fig.
14 C). Displacement is more marked for high-[Ca21]i
(depolarized) than for low-[Ca21]i (hyperpolarized) states
where the effect of Ca21 currents through VOCCs is mini-
mal. This distinction suggests that the effects of nifedipine
will be most pronounced in the depolarized range around
0 mV rather than when the membrane is hyperpolarized.
3. Reductions inGK to simulate blockade of KCa channels by
charybdotoxin deﬂect the dz/dt curves upward by effec-
tively rotating them around the KCa reversal potential at
;95 mV (Fig. 14 D). Note that for low values of GK
crossings of the horizontal axis at P1 and P2 may dis-
appear, leaving only the depolarized stable point P3. This
suggests that under certain circumstances trajectories will
jump to an equilibriumwhere oscillations are not observed.
4. The two distinct pharmacological interventions used to
probe the contribution of Cl channels to vasomotion can
be understood in an analogous fashion. Substitution of
extracellular Cl by sodium isethionate will enhance
extrusion of this ion from the intracellular compartment
and was modeled by a 17-mV stepwise increase in the
reversal potential for chloride ions, DzCl. This approach
resulted in a direct upward translation of the dz/dt curves
and was associated with a membrane depolarization Dz of
;10 mV (Fig. 14 E). Simulations (not shown) conﬁrmed
that the scaling between DzCl and Dz is determined largely
by coefﬁcient GCl and is essentially independent of other
model parameters, as suggested by inspection of Eqs. 3 and
4. Cl substitution will thus result in a stepwise membrane
depolarization of effectively constant magnitude (e.g., Fig.
13 A). By contrast, blockade of Cl channels by niﬂumic
acid rotates the dz/dt curves anticlockwise around the Cl
reversal potential. This causes hyperpolarization below the
Cl reversal potential (as will normally be the case in the
physiological situation), but depolarization above this
potential (Fig. 14 F).
By employing the three-variable model, it is possible
to visualize the dynamical attractor of the system as a
three-dimensional plot of [Ca21]i versus [Ca
21]SR versus
membrane potential. Such an attractor and its evolution in
time after stepwise changes in drug concentrations are
presented in Fig. 15 for each individual pharmacological
intervention. The shape of the attractor, shown in Fig. 15 A,
for stepwise changes in the coefﬁcients A, Cr, and GCa
suggests a general trend from high [Ca21]i (low [Ca
21]SR),
where no oscillatory behavior can occur, to a regime of
sustained large amplitude oscillations that are ultimately
suppressed at low [Ca21]i (high [Ca
21]SR), an overall
scenario that can describe the action of U73122, ryanodine,
and nifedipine (Fig. 15, A–C). Pharmacological agents that
indirectly affect [Ca21]i by causing changes in membrane
potential, such as charybdotoxin, isethionate, and niﬂumic
acid (Fig. 15, D–F), induce a different effect as they translate
the attractor parallel to the z axis in association with ultimate
suppression of oscillatory activity. Antagonism between K1
and Cl channels becomes apparent by noting the opposite
trends in Fig. 15,D and F, in which blockade of K1 channels
by charybdotoxin promotes depolarization, and blockade of
Cl channels by niﬂumic acid promotes hyperpolarization.
It should be noted that in all simulations presented in
previous sections neither K1 nor Cl channels were assumed
to be activated by Ca21, i.e., b ¼ 0 and xCl ¼ 0, so that their
contribution to membrane potential in Eq. 3 simpliﬁes to
GKðz zKÞ and GClðz zClÞ: Simulations of the action of
charybdotoxin with b ¼ 0 and 0.1 (i.e., in the absence and
FIGURE 10 Bifurcation analysis of [Ca21]i oscillations constructed by
varying the parameters GCa (VOCCs) and A (NSCCs). (A) GCa was varied
from 30.0 to 0.0, whereas A was varied from 0.1 to 3.3. Decreases in GCa
demonstrate the occurrence of a Hopf bifurcation followed by a reverse Hopf
bifurcation when GCa is further decreased. The reverse Hopf bifurcation
occurs outside the physiological range (i.e., GCa, 0) for large A values, thus
indicating that oscillatory activity may either be abolished (low A) or sustained
(high A) after blockade of VOCCs. (B) Corresponding time series illustrating
the oscillatory and nonoscillatory domains in GCa-A parameter space.
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presence of Ca21 dependence) showed that equal reductions
in the coefﬁcient GK suppressed oscillatory activity more
quickly for b ¼ 0.1 (Fig. 16 A). The effects of Ca21
dependence of the Cl channels were investigated by com-
paring the action of 1), isethionate with xCl ¼ 0 and 0.1; and
2), niﬂumic acid with xCl ¼ 0 and 0.15. Isethionate
suppressed oscillatory activity more slowly when Ca21
sensitivity of Cl channels was incorporated in the model
(Fig. 16 B), whereas niﬂumic acid suppressed oscillations
more rapidly (Fig. 16 C).
DISCUSSION
The aim of this study was to develop and validate a minimal
mathematical model of the interacting ion transport systems
that regulate smooth-muscle tone and underpin vasomotion
in the rat basilar artery. The model incorporates three non-
linear differential equations to describe the regulation of free
cytosolic [Ca21], [Ca21] in intracellular stores, and smooth-
muscle membrane potential and was formulated on the basis
that the ‘‘macroscopic’’ rhythmic behavior of the arterial
wall reﬂects ion movements occurring at the level of the
single cell. Empirically, this assumption can be justiﬁed on
the basis that the onset of vasomotion coincides with the
synchronization of intracellular Ca21 oscillations and intra-
cellular waves in large populations of smooth muscle cells
(7,9–11,13). To validate the approach, system parameters
determining a range of ionic ﬂuxes were varied to model
pharmacological interventions, and these simulations com-
paredwith correspondingexperimentalmeasurementsof smooth-
muscle membrane potential, [Ca21]i, and vascular caliber.
FIGURE 12 A reduction in the coefﬁcient
GK of Eq. 3 was used to simulate the action of
charybdotoxin. (A) Oscillatory activity was
almost abolished when GK was reduced from
43 to 28, in association with marked mem-
brane depolarization and increased [Ca21]i.
(B) Experimentally, charybdotoxin (60 nM)
markedly reduced the amplitude of contrac-
tile and electrical activity and caused mem-
brane depolarization. The residual activity
exhibited an increase in frequency. (C and D)
Oscillations in wall Ca21 and in individual
smooth muscle cells were similarly increased
in frequency with a rise in mean [Ca21].
FIGURE 11 Nullcline analysis illus-
trating the stability characteristics of the
system under the variation of (A) pa-
rameters Cr andGCa (with A¼ 0.5), and
(B) parameters Cr and A (with GCa ¼
12). Dashed and solid lines denote the x
and y nullclines; open and solid circles
denote unstable and stable equilibrium
points.
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Cytosolic Ca21 cycling via the RyR and InsP3R
In the rat cerebral artery, ryanodine suppressed oscillations in
membrane potential and [Ca21]i, consistent with studies in a
range of rat and rabbit arteries that have previously demon-
strated an essential role for stores expressing the RyR in the
genesis of vasomotion, and in which ryanodine has been
found to attenuate or abolish rhythmic mechanical activity
and oscillations in smooth-muscle [Ca21] and membrane
potential (1,4,5,7,8,17,56). By contrast, in rat portal vein
myocytes the regulation of [Ca21]i involves cooperativity
between the RyR and the InsP3R, with oscillatory activity
FIGURE 13 (A) Action of sodium
isethionate simulated by introducing a
stepwise change in the Cl channel
reversal potential zCl by aDzCl of 17mV,
which resulted in signiﬁcant membrane
depolarization, a slight rise in average
[Ca21]I, and suppression of oscillatory
behavior. (B–D) Experimentally, chlo-
ride substitution with 120 mM sodium
isethionate caused depolarization and
abolished rhythmic contractile activity
and Ca21 oscillations and also caused a
small increase inmean [Ca21]i. (E) Sim-
ulation of the action of chloride channel
blocker niﬂumic acid by reducing coef-
ﬁcient GCl from 65 to 0 (with A ¼ 1.0)
resulted in hyperpolarization and a
reduction in [Ca21]i. (F–H) Experimen-
tally, niﬂumic acid resulted in hyperpo-
larization and a reduction in [Ca21]i with
an associated loss of rhythmic activity.
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FIGURE 14 (A) Over the physiological range, individual components contributing to membrane potential include K1 efﬂux, which promotes
hyperpolarization, whereas Cl efﬂux and Ca21 inﬂux through VOCCs both promote depolarization. The role of Na1/Ca21 exchange is variable because of the
Ca21 dependence of the reversal potential of this exchange mechanism. A hypothetical composite dz/dt plot (see Eq. 3) shows that three possible steady states
occur at points of intersection with the horizontal axis (P1 and P3, stable; P2, unstable). (B) Family of dz/dt plots encompassing the physiological range, with
each plot corresponding to a distinct value of [Ca21]i at intervals of 0.05 mM, as indicated. The plots provide insight into the hyperpolarizing action of U73122
as this agent decreases [Ca21]i. (C) The effects of nifedipine were modeled as a reduction ofGCa to generate two families of dz/dt plots, each covering the range
[Ca21]i ¼ 0.1–0.9 mM. Theoretical effects of nifedipine on membrane potential are indicated by arrows at the same value of [Ca21]i and show that
hyperpolarization is most marked in depolarized vessels when [Ca21]i is high. (D) Analogously, the depolarizing effects of charybdotoxin were modeled by
reducing GK to generate two families of plots encompassing different values of [Ca
21]i. The corresponding depolarizations are indicated by arrows. (E and F)
A similar approach was used to understand the role of Cl channels after substitution by isethionate or administration of niﬂumic acid. These simulations
respectively demonstrate depolarization and hyperpolarization.
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FIGURE 15 (A) U73122, simulated as stepwise reductions in term A, promotes membrane hyperpolarization and suppression of oscillatory activity. (B)
Ryanodine, simulated as stepwise increases in coefﬁcient C, is associated with a gradual reduction in oscillatory amplitude as [Ca21]SR is reduced and stores
are gradually depleted. There is minimal effect on average [Ca21]i and membrane potential. (C) Nifedipine, modeled as stepwise decreases in coefﬁcient GCa,
causes a reduction in both [Ca21]i and membrane potential. (D) Charybdotoxin, simulated as decreases in coefﬁcient GK of Eq. 3, induces marked
depolarization and an increase in [Ca21]i. (E) Chloride substitution by isethionate, modeled as changes in zCl, produced marked membrane depolarization,
associated with a small increase in mean [Ca21]i and ultimate suppression of oscillatory activity. (F) Chloride channel blocking by niﬂumic acid produced
hyperpolarization and reduced [Ca21]i. Arrows indicate the direction in which the attractor translates during intervention.
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speciﬁcally dependent on InsP3R2, rather than InsP3R1 or
InsP3R3, and only partially suppressed by ryanodine (35,57).
Since the RyR and the InsP3R can thus both contribute to the
genesis of oscillatory behavior in vascular smooth muscle
cells, we simulated the theoretical contributions of each class
of receptor using amonotonically increasingHill sigmoidal to
describe the Ca21 kinetics of the RyR channel and a biphasic
dualHill sigmoidal to describe theCa21 kinetics of the InsP3R
channel.
Modeling studies conﬁrmed that oscillatory activity could
in principle be supported by either channel type, and nullcline
analysis provided insights into similarities and differences in
their contribution to the dynamics of the system of three
differential equations used to model the smooth muscle cell.
The general form of the x and y nullclines in simulations
separately incorporating the RyR or the InsP3R was similar at
[Ca21]i levels ,1 mM. In both cases, parameter choices that
maintained a high level of [Ca21]SR generally fell in a
nonoscillatory regime, but on increasing channel open
probabilities (Cr and Ci) or sensitivity to activation by Ca
21
(xr and xi) the nullcline intersection translated downward,
thereby allowing the emergence of a limit cycle that encircled
an unstable equilibrium point, although there was then a
progressive decrease in the size of the limit cycle until the
system regained stability and oscillations ceased. It follows
that activation of either the RyR or the InsP3R may in theory
either promote or suppress oscillatory behavior, according to
initial parameter choices. Notably, oscillatory behavior was
observed only when their activating Hill slopes (pr and pi)
were .3, and high values of these coefﬁcients increased the
size of the associated limit cycle and reduced oscillation
frequency, whereas the Hill exponents for Ca21 release (mr
andmi) inﬂuenced the size of the associated limit cycle but not
the existence of oscillatory activity. Thus, the activating
mechanisms of the RyR and the InsP3R appear to be key in
generating oscillatory activity. This conclusion is consistent
with the reportedly speciﬁc ability of the InsP3R2 to support
oscillatory behavior, since this subtype possesses an intrin-
sically higher Hill coefﬁcient for activation by Ca21 than the
InsP3R1 or InsP3R3 (40,58,59).
As would be expected, the inactivating component of the
InsP3R kinetics served to maintain Ca
21 levels within the
sarcoplasmic reticulum store and thereby elevated the posi-
tions of the x and y nullclines relative to those associated
with the RyR for [Ca21]i.1 mM. The Ca
21 release phase of
the oscillatory cycle, and thus oscillation amplitude, was
consequently abbreviated, and there was also an associated
reduction in the duration of the store reﬁlling phase that
determines oscillation frequency. Decreases in the coefﬁcient
hi of the dual InsP3R sigmoidal, which mimics the biological
FIGURE 16 (A) Simulated action of charybdotoxin for two levels of Ca21-dependence of KCa channels. Four stepwise changes in GK are included in each
time series plot (GK ¼ 43, 37, 29, and 25). (B) Simulated time series for the action of isethionate for two levels of Ca21 dependence of Cl channels. Four
stepwise changes in zCl are included in each time series plot (DzCl ¼ 0, 10, 18, and 20 mV). (C) Simulated action of niﬂumic acid under the same conditions as
in B. Stepwise changes in GCl are included in each time series (GCl ¼ 65, 35, 10, and 0, for A ¼ 0.9).
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effects of increased [InsP3] on the InsP3R by causing a
leftward shift in the InsP3R open-probability curve to lower
Ca21 levels (39,41,42), accentuated this important difference
between the RyR and InsP3R. Although it is often stated in the
literature that the biphasic nature of the InsP3R open-
probability curve is crucial for the genesis of oscillatory
activity by allowing sequential Ca21-dependent activation
and inactivation of the channel, this assumption was shown to
be incorrect in the open system described here, since nullcline
analysis indicated that InsP3R-dependent oscillations devel-
oped around an unstable equilibrium point with dynamics
generically similar to that of the RyR. This situation differs
fundamentally from closed-cell models in which there is no
inﬂux of extracellular Ca21. In such systems oscillatory
activity has an obligatory dependence on the separation of the
timescales that deﬁne the kinetics of InsP3R activation and
inactivation rather than the speciﬁc form of the quasisteady
open probability curve, i.e., whether the curve is biphasic or
monotonically increasing (60,61).
The theoretical consequences ofmanipulatingRyR activity
in simulations were compared with the effects of ryanodine in
rat cerebral arteries. At low concentrations ryanodine in-
creases the open-state probability of the RyR and its
sensitivity to Ca21 ions, before locking the channel in an
open subconductance state and ultimately causing complete
channel closure at high concentrations (28,54,55). Experi-
mentally, 10 mM ryanodine decreased the amplitude of
oscillations in membrane potential and [Ca21]i and increased
vasomotion frequency, and these observations could be
simulated by increasing the open probability of the RyR (Cr)
or its sensitivity to Ca21 (xr), consistent with the reported
effects of low concentrations of ryanodine. Increasing the leak
of Ca21 ions from the store (L), which may be considered as
shifting the RyR to an open subconductance state, matched
the effects of ryanodine on oscillatory amplitude, whereas
vasomotion frequency was essentially unaffected. These
ﬁndings were shown to apply over a broad range of values of
Cr, xr, and L. Decreasing the coefﬁcient Cr to simulate the
closure of the RyR channel reported after administration of
high concentrations of ryanodine caused an increase in
oscillation amplitude and slowed vasomotion frequency, thus
contrastingwith the experimental ﬁndings. Additional studies
would therefore appear necessary to clarify concentration-
dependent effects of ryanodine on vasomotion, since the
simulated effects of reductions inCr would be consistent with
the reduced frequency and increased amplitude of phenyl-
ephrine-induced vasomotion reported in rat small mesenteric
arteries after administration of 40mMryanodine (12). Further
experiments are also required to deﬁne the contribution of the
InsP3R to vasomotion in rat arteries since immunostaining has
shown that InsP3R1 is the only InsP3R present in the smooth
muscle of the rat aorta and mesenteric artery, whereas in the
rat basilar artery there is also expression of InsP3R2, although
this is much weaker than that of the InsP3R1 (24). Such
ﬁndings also suggest that regenerative Ca21 release via the
RyR is likely to be the dominant CICR mechanism in rat
arteries, since rhythmic activity can be observed in each of the
three vessel types (7,8,62),whereas the ability of the InsP3R to
mediate oscillatory behavior is reportedly speciﬁc for the
InsP3R2 subtype, as noted above.
Numerous studies have provided evidence that crosstalk
between the RyR and the InsP3R can play an important role in
Ca21homeodynamics. In rat portalveinmyocytes, for example,
positive cooperativity between Ca21-release sites are thought
to enhance local release of Ca21 from a common store, such
that opening of the InsP3R by InsP3 underpins periodic
ﬂuctuations in [Ca21]i through the recruitment of neighboring
RyR channels (57,63). An analogous phenomenon could be
simulated in this model by selecting an initial value of Cr that
was associated with a high value of [Ca21]SR in a non-
oscillatory regime, and then increasing the value ofCi so as to
mimic the progressive superposition of InsP3R-mediated
CICR. This strategy resulted in the emergence of an unstable
nullcline intersection and associated limit cycle. Alternative
possibilities, reported experimentally in colonic and pulmo-
nary artery myocytes, respectively, is that the depletion of the
SR Ca21 store that follows the opening of RyR channels
attenuates the availability of Ca21 for release via the InsP3R,
and vice versa (64,65). Both scenarios could be reproduced by
selecting values of Ci and Cr such that the system was in an
intermediate oscillatory regime, after which increases in
either Cr or Ci, respectively, reduced [Ca
21]SR to a level that
was no longer capable of sustaining oscillatory behavior
because the nullcline intersection then became stable. The
model was also able to reproduce observations that InsP3R-
mediated CICR can sometimes appear to dominate oscillatory
behavior to the extent that repetitive cytosolic Ca21 spiking is
unaffected by administration of ryanodine, e.g., in colonic
myocytes (64). Increases in Cr with a ﬁxed value of Ci could
thus result in an increase in the oscillation frequency without
change in amplitude. This phenomenon occurs because the
progressive dominance of the RyR ﬂattens the x and y
nullclines for [Ca21]i.1 mM, with the overall effect that the
oscillatory limit cycle translates downward, but, in contrast to
the situation for the RyR alone, is not associated with
alterations in amplitude even though there was a progressive
fall in [Ca21]SR. By contrast, the theoretical analysis of Eq. 4
suggests that neither the RyR- nor the InsP3R-mediated CICR
mechanisms can be a key determinant ofmean [Ca21]i. Indeed,
this experimental data indicate that ryanodine can suppress
vasomotion in the rat basilar artery without exerting major
effects on mean wall [Ca21]i or [Ca
21]i in individual smooth-
muscle cells, and ryanodine has also been shown to abolish
oscillatory ﬂuctuations in pressure in perfused rabbit arterial
segments without affecting mean perfusion pressure (5,17).
Membrane potential and integrated ion ﬂuxes
None of the transmembrane ionic currents incorporated in
the model was assigned the status of an independent variable.
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Nevertheless, since multiple currents were included in the
equation that represented the net rate of change in membrane
potential, dz/dt, the model was capable of evaluating the effects
of pharmacological blockade of the participating membrane
ﬂuxes. As shown in Fig. 14, the dz/dt curve intersects the
horizontal axis at a maximum of three points, which represent
possible steady states where oscillations in membrane potential
and [Ca21]i are abolished, with the central equilibrium point
(P2) unstable, but the outer points (P1 and P3) stable, and by
plotting families of composite dz/dt curves for discrete
values of [Ca21]i, it was possible to delineate the dynamical
effects of speciﬁc interventions in terms of mean [Ca21]i and
membrane potential. To illustrate the general behavior of the
model, these simulations were performed only for RyR-
mediated CICR employing an activation coefﬁcient of 4.
The open system discussed here necessarily requires inﬂux
of extracellular Ca21 into the cytosol to maintain oscillatory
activity, and this was provided principally by NSCCs and
VOCCs. Simulations of the action of the PLC inhibitor
U73122 demonstrated theoretically how reduced Ca21 inﬂux
via NSCCs after the suppression of DAG formation (modeled
as reductions in the coefﬁcient A) should decrease mean
smooth-muscle [Ca21]i, promote hyperpolarization, and
abolish rhythmic activity, and these ﬁndings matched the
experimental effects of U73122. For speciﬁc values of A,
simulated blockade of VOCCs by nifedipine (modeled as
reductions in the coefﬁcient GCa) could also result in de-
creases in [Ca21]i, promote hyperpolarization and cause a
reduction in the amplitude of [Ca21]i and membrane potential
oscillations, thus matching the experimental effects of ni-
fedipine on these parameters and vessel diameter. In terms of
integrated ion ﬂuxes, reductions in GCa depressed the bell-
shapedmaximum in the rate of change ofmembrane potential,
dz/dt, at membrane potentials close to 0 mV, with a leftward
displacement in the P1 stable equilibrium and an associated
hyperpolarization that was more marked for depolarized than
hyperpolarized states, thus reﬂecting the open probability of
voltage-operated Ca21 channels. Such simulations accord
with published data for hamster arterioles exhibiting sponta-
neous rhythmic activity in vivo, in which nifedipine abolishes
vasomotion and causes sustained hyperpolarization and
dilatation (66).
The roles of NSCCs and VOCCs were further explored by
formal bifurcation analysis, which conﬁrmed that oscillatory
behavior was possible only when the net Ca21 ﬂux into the
cytosol from the extracellular space via these channels fell
within a critical range. A two-dimensional bifurcation dia-
gram for [Ca21]i oscillations illustrating the interaction of
Ca21 ﬂuxes via NSCCs and VOCCs during manipulation of
their respective control parameters (i.e., A and GCa) demon-
strated that oscillatory activity arose via a Hopf bifurcation
and ceased at a reverse Hopf bifurcation. Nullcline analysis of
the model also highlighted the complex interaction between
extracellular Ca21 inﬂux and RyR-mediated CICR from
stores during variations inA,GCa, andCr. For combinations of
these parameters within the physiological range, the model
exhibited oscillatory activity, but for both high and low values
of A or GCa, oscillations were suppressed. Experimental evi-
dence that inﬂux of extracellular Ca21 can induce rhythmic
activity by speciﬁcally activating RyR-mediated CICR has
been obtained in rat renal afferent arterioles in which the
opening of VOCCs by BAYK-8644 induces pronounced
ryanodine-sensitive vasomotion (56).
Vascular smooth-muscle membrane potential is strongly
inﬂuenced by the balance between K1 and Cl movements,
which compete to drive cell potential toward their respective
reversal potentials at approximately 95 and 25 mV.
Although neither channel was ascribed the status of an
independent variable in this three-variablemodel, simulations
allowed a detailed analysis of the role of K1 and Cl channels
in the genesis of rhythmic activity and provided insights into
the functional consequences of their activation by Ca21 ions.
For example, simulating the action of charybdotoxin by
reducing the coefﬁcient GK resulted in depolarization and
suppressed oscillatory activity, as observed experimentally.
Simulations also indicated that these effects of charybdotoxin,
which blocks large- and intermediate-conductance Ca21-
activated K1 channels, become apparent earlier when the
Ca21-dependence of the KCa channel is strong. The exper-
imental effects of manipulating smooth-muscle Cl ﬂuxes
with isethionate or niﬂumic acid were closely matched by
simulations involving stepwise changes in the reversal poten-
tial for the Cl ion or reductions inGCl, respectively. Speciﬁc
consequences of the [Ca21]i dependence of Cl
 channels on
vasomotion could not be evaluated experimentally, since no
speciﬁc blockers of such channels are available. However,
simulations suggested that an enhanced [Ca21]i dependence
of the Cl channel will extend or reduce the range of
oscillatory activity, according to whether the role of such
channels is probedwith isethionate or niﬂumic acid, which act
in opposing ways to increase and decrease the efﬂux of Cl
ions. Importantly, the model was still capable of generating
oscillatory behavior when neither channel was conferred with
sensitivity to Ca21 (i.e., coefﬁcientsb and xCl were both set to
zero), and that the qualitative effects of other superimposed
pharmacological interventions were then essentially un-
changed, albeit shifted to different parameter ranges. It
follows that vasomotion does not have an obligatory require-
ment for the Ca21 dependence of either K1 or Cl channels,
although they may still play an important modulatory role in
the genesis of oscillatory activity in the absence of Ca21
sensitivity. Transmembrane K1 and Cl ﬂuxes are governed
by the instantaneous difference between their respective re-
versal potentials and membrane potential, which will neces-
sarily oscillate as a result of ryanodine-sensitive CICR (for
example, as a result of Na1-Ca21 exchange in this model).
In general, the system was found to support sustained
oscillatory activity only within a physiological range of
[Ca21]i, [Ca
21]SR, and membrane potential, beyond which the
behavior of the system collapsed toward stable equilibrium
Three-Variable Model of Vasomotion 1553
Biophysical Journal 93(5) 1534–1556
points via different pathways. Cessation of oscillatory activity
may thus result from ‘‘overstimulation’’ of the system, when
cellular Ca21 inﬂux is high, in which case the concentrations
of Ca21 present in the SR store and the cytosol are both too
high to support cyclical release of Ca21 from the SR into the
cytosol, or ‘‘understimulation’’ when Ca21 reuptake is low,
in which case the store does not ﬁll sufﬁciently to support the
CICR mechanism. Similarly, strongly hyperpolarizing condi-
tions suppress Ca21 inﬂux via voltage-operatedCa21 channels
and strongly depolarizing conditions promote Ca21 inﬂux via
this pathway and thus ‘‘understimulate’’ or ‘‘overstimulate’’
the cell, respectively. These different scenarios were illus-
trated by the various pharmacological probes employed in this
study and were visualized by constructing the phase-space
attractor of the system. Thus, U73122, ryanodine, and nifed-
ipine translated the attractor in the direction of the [Ca21]i and
[Ca21]SR axes, simultaneously affecting oscillation ampli-
tude and ultimately membrane potential. By contrast, agents
that directly affectmembrane potential, such as charybdotoxin,
isethionate, and niﬂumic acid, translated the attractor pri-
marily in the direction of the axis depictingmembrane poten-
tial, thus also affecting oscillatory amplitude and indirectly
[Ca21]i.
Conclusions and future studies
This study has shown that a three-variable model of the
smooth muscle cell can provide a close representation of
pharmacologically induced changes in smooth-muscle mem-
brane potential and cytosolic [Ca21]i during spontaneous
vasomotion in isolated rat cerebral arteries. One important
assumption of the model is that coupled vascular smooth-
muscle cells can synchronize their activity in such a way that
vasomotion closely reﬂects ion movements at the level of the
individual cell. To examine this hypothesis in more detail, the
model could be extended to deﬁne the conditions that permit
global entrainment of the intracellular Ca21 waves that occur
in individual smooth muscle cells, thereby allowing the
emergence of ‘‘macroscopic’’ rhythmic activity. Although it
is well-established that the synchronization of Ca21 oscilla-
tions in vascular smooth muscle cells is dependent on gap
junctional communication (6,13,14), it remains unclear
whether the dominant intercellular coupling mechanism is
electrical or chemical in nature. For completeness, further
modeling studies should therefore incorporate the cytoplas-
mic distribution of stores expressing the RyR and the InsP3R,
intracellular and intercellular diffusion of Ca21 ions and
InsP3, as well as electrical coupling between adjacent cells.
Such studies are likely to suggest experimental approaches
that can be tested pharmacologically and thereby clarify the
signaling pathways that lead to emergent behavior.
One advantage of this three-variable formulation of the
smooth muscle cell is that it focuses on the contribution of a
cytosolic oscillator to vasomotion, thus allowing nullcline
analysis to provide clear insights into differences and sim-
ilarities in the dynamics of CICR via the RyR and InsP3R,
and the crosstalk that is possible between these Ca21-release
channels. The model also allows the interaction between
CICR and membrane transport systems to be investigated in
a relatively tractable way, and has provided evidence that the
sensitivity of membrane K1 and Cl channels to activation
by Ca21 ions is not essential for the existence of rhythmic
activity, at the same time demonstrating that the Ca21 sen-
sitivity of such channels determines the parameter ranges
over which rhythmic activity becomes manifest. A more
complex, compartmentalized model would also allow delin-
eation of how stores located close to the cell membrane might
target and activate KCa and ClCa channels in a spatially
selective fashion (67–69). Previous experimental studies have,
for example, provided evidence that localized RyR-mediated
CICR can open KCa channels in the absence of signiﬁcant
changes in cytosolic [Ca21]i (69), although this phenomenon
did not appear to be a dominant consideration in this study,
since ryanodine did not exert major effects on membrane
potential. Since the intracellular Ca21 waves that propagate
through individual smooth muscle cells during vasomotion
can markedly reduce the frequency of RyR-mediated Ca21
sparks (9), the conditions under which Ca21 oscillations
might override and suppress localized elementary events by
entraining the CICR mechanism remain to be clariﬁed by
modeling and experimental studies.
A particular feature of this model is that the dynamics of a
three-variable system is governed by a three-dimensional
attractor, thereby allowing full visualization of the relation-
ship between membrane potential, [Ca21]i, and [Ca
21]SR
during simulated pharmacological interventions. The pat-
terns of vasomotion that were observed in nonperfused rat
cerebral arteries in this study were relatively simple and
readily generated by the three-variable model. However, it
should be noted that vasomotion in intraluminally perfused
rabbit and rat arterial segments often exhibits more complex
nonlinear behavior that is closely associated with chaos,
including period-doubling, quasiperiodicity, mixed-mode
responses, and intermittency (15–19). One apparent limita-
tion of the this three-variable approach, therefore, is that such
generic patterns of chaotic behavior could be simulated only
within a very restricted range, when the coefﬁcients of Eqs.
1–3 were assigned values that were generally outside the
physiological range (data not shown). By contrast, a four-
variable model of the smooth muscle cell, in which the open-
state probability of Ca21-activated K1 channels was assigned
the status of an additional independent dynamical variable,
has previously been shown to generate a wide range of non-
linear responses, principally because it allows the coupling
of distinct but interacting nonlinear membrane and cytosolic
oscillators (each of which requires two independent control
variables) (17). It should be noted, however, that it is also
possible to generate rich chaotic behavior by coupling nearly
identical limit-cycle oscillators such as those developed in
this work. Further studies are therefore necessary to compare
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the advantages and disadvantages of a coupled-cell approach
rather than a single high-order system of differential equa-
tions to model vasomotion.
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